In 2023, Jackie Coté had just been diagnosed with metastatic breast cancer. Feeling shocked and overwhelmed, she and her friend Nancy Gill, who accompanied Coté to her appointment, silently made their way to the front desk to schedule Coté’s weekly chemotherapy. As Coté entered the appointments into her phone calendar, Gill did the same in … Read more
While participating in a clinical trial, Kathleen McEvoy-Schufreider, a 60-year-old communications executive living in Haverhill, Mass., traveled to Dana-Farber for scans every twelve weeks to monitor her cancer. In between appointments, it was hard to put the scans out of her mind. “I was living in twelve-week bursts,” says McEvoy-Schufreider, who was diagnosed with early-stage … Read more
It is now possible to perform cervical cancer screening from the comfort of your own home with a prescribed at-home test approved by the U.S. Food and Drug Administration. The approved test enables people to collect their own vaginal samples at home and mail them in to a certified lab for testing. The test provides … Read more
Among cancer diagnoses, prostate cancer is relatively common, especially for those who are older than 65. Fortunately, it is often manageable with minimal interventions necessary for a substantial portion of patients. However, many prostate cancer cases can be categorized as “aggressive,” meaning it will require more extensive treatment to address or avoid metastasis (spread of the cancer). … Read more
Cancer research often focuses on gene mutations in the parts of the human genome that produce cellular machinery called proteins. But the rest of the genome — sometimes called the “dark genome” — can also play a role. Dana-Farber researcher William Freed-Pastor, MD, PhD, a physician-scientist in the Dana-Farber Center for Gastrointestinal Oncology and Hale … Read more
The first time Jackie Dunn tracked her husband Mike’s numbers, he was a high school basketball star and she was the team statistician. More than 40 years later, she was back at it — this time with far more on the line than a ballgame. The Dunns had temporarily relocated in the summer of 2024 … Read more
Medical advances tend to unfold slowly over many years, fueled by successive clinical studies that build upon each other and together provide the evidence needed to change patient care. A key illustration of this point comes from a recent phase 3 clinical trial, published last October in the New England Journal of Medicine (NEJM), which … Read more
While planning her annual breast cancer fundraiser in Hull, Mass., Ellie Destito’s friends learned some surprising news. For the first time, their friend revealed that she was living with breast cancer herself. “They had no idea,” recalls Destito, who was first diagnosed with breast cancer back in 2008. Through the years, she was treated with … Read more
When Pedro Vianna, MD, was 5 years old, his mother took him to the pediatrician in their home country of Brazil. A lymph node on the left side of his neck had been swollen for weeks. While the pediatrician reassured his family that it was likely a reactive viral infection, Vianna’s mother, a hematologist, had … Read more
After her breast cancer surgery, Tia struggled with mobility in her left shoulder. It felt as though the joint was frozen, and she could feel some swelling in her chest. After several dead ends, she learned that this feeling may be caused by early-stage lymphedema. This condition is a common side effect of breast cancer … Read more
Kirsten Dahl knows plenty about targets, so when she was diagnosed with an aggressive form of HER2+ breast cancer, she devised her own unique brand of targeted cancer therapy. In addition to heeding the advice of her medical team, Dahl focused on the one thing she most missed to help her get through nearly two … Read more
The human genome is a sequence of Ts, Gs, Cs, and As that is about 3 billion letters long. And, says Bradley Bernstein, MD, PhD, chair of Dana-Farber’s Department of Cancer Biology, “there’s no dictionary or guide for reading it.” Bernstein is trying to make such a resource. The efforts so far, carried out by … Read more
Dana-Farber’s Older Adult Gastrointestinal Cancer Program specializes in treating patients who are 65 and older and have gastrointestinal cancers, such as colorectal cancer, esophageal and gastric cancer, liver cancer, neuroendocrine and pancreatic cancer. “Older adults are richly complex and multidimensional,” says gastrointestinal and geriatric oncologist Nadine McCleary, MD, MPH, who leads the program. “They deserve … Read more
In March 2016, two months before joining Dana-Farber, Sara Menendez, LAT, ATC, attended LYNKED IN, an annual one-day conference hosted by Dana-Farber’s Lynch Syndrome Center. The event gave her an opportunity to meet colleagues and learn about treatment advances, screening guidelines, and prevention efforts for Lynch syndrome, an inherited and often underdiagnosed condition that increases … Read more
In December 2023, a space opened in a clinical trial at Dana-Farber of a novel targeted drug. Rosemary Conway, 68, who had stage IV lung cancer, was eager to fill it. She had been waiting nearly six years for a trial of a medicine that would target a specific genetic mutation driving the growth of … Read more
In recent decades, rates of some cancers, such as colorectal cancer, have been rising in young adults under the age of 50. One possible explanation for this rise is a parallel rise in obesity rates and changes in diet, activity levels and lifestyle. However, says Kimmie Ng, MD, MPH, director of Dana-Farber’s Young-Onset Colorectal Cancer … Read more
People with Lynch syndrome have an elevated risk of developing colon cancer and several other cancers. For example, someone without the inherited condition has about a 5% chance of developing colon cancer. But for someone with Lynch syndrome, it could be anywhere from 22% to 74%. What if there were a way to reduce the … Read more
The number of people seeking care at the Butaro Cancer Center of Excellence in Rwanda has been rising consistently over the last decade. Prior to that, very few people in Rwanda received cancer care, not because no one had cancer but because Rwanda had virtually no cancer care services. Over the last 12 years, the … Read more
Dana-Farber’s genitourinary cancer team is devoted to research that will advance patient care and improve patient’s lives. Recently, that research — all of it years in the making — has paid off with major achievements. This includes: “We are constantly striving to improve the treatment and diagnosis of genitourinary cancers,” says Toni Choueiri, MD, director … Read more
Menin, a protein located in the nucleus of various human cell types, often functions as a tumor suppressor by inhibiting excessive cell growth and division. It facilitates a complex of proteins involved in a cellular process called histone methylation, where chemical units called methyl groups are added to histone proteins that anchor DNA, thereby activating … Read more